Search

Roundtable Discussion: Marijuana Rescheduling, Cannabidiol (CBD) Product Pathways, and More While interest in cannabis and cannabis-derived products remains high, the near- and long-term future of federal regulation remains hazy. Hear directly from FDA as they discuss regulation and enforcement in...

In a conversational 30-minute forum over Zoom, Saul Ewing attorneys hosted a discussion on emerging industry developments and common issues that cannabis businesses face today. This month's program featured content covering current regulatory landscape and how it impacts your business. Interested in...

FORT LAUDERDALE, (MARCH 7, 2024) – In joining Saul Ewing as a new partner, Zachary Kobrin brings his insight from having served as general counsel for two companies to his work as a transactional and regulatory lawyer with a focus on cannabis, antitrust and other corporate law. He works in the firm...

On February 14, 2024, the Delaware Office of Marijuana Control (OMC) released draft regulations for the state’s adult-use cannabis market. Public comment is due on or before March 29, 2024. These regulations include the rules applicable to the licensing of adult-use cannabis businesses; the...

New requirements arising from the Corporate Transparency Act of 2019 took effect on Jan 1, 2024. If your small business is formed as an entity that meets the definition of a “Reporting Company” under the Act, your organization will have to report information about their beneficial owners, i.e., the...

2023 was an active year in both the cannabis and psychedelics spaces, with significant developments across policy, research, litigation, and beyond. While states have largely led on the policy front, we expect increased federal attention in both areas this year, in addition to continuation of state...